Stay updated on Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Melanoma content and the MedlinePlus Genetics related topics were removed from the page.
    Difference
    0.1%
    Check dated 2026-03-04T15:07:30.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Melanoma topic, MedlinePlus Genetics link, and a new JAMA Netw Open citation related to adjuvant pembrolizumab in melanoma.
    Difference
    0.1%
    Check dated 2026-02-25T10:29:40.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    A new site revision label, v3.4.2, was added and an older revision (v3.4.1) along with some topic tags (Melanoma, MedlinePlus Genetics, related topics) were removed. These appear to be administrative updates to the page's metadata.
    Difference
    0.2%
    Check dated 2026-02-11T06:19:36.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and operations; Melanoma related topics were added, and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T05:15:42.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Added a glossary toggle and Plain Language Summary, plus IPD sharing information and related links (IPD Sharing Url and IPD Plan Description). Also included Merck-related information sections and downloadable documents (Study Protocol and Statistical Analysis Plan).
    Difference
    100%
    Check dated 2026-01-28T03:04:34.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    Added related topic links for Melanoma and MedlinePlus Genetics on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-21T01:00:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.